빌리루빈 대사와 빌리루빈 뇌증
Bilirubin Metabolism and Bilirubin Encephalopathy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
During the last 30 years, there has been much advances in the understanding of pathogenisis of neonatal hyperbilirubinemia, but the risk of bilirubin encephalopathy are still remained for the high risk neonates. The mechanisms of bilirubin encephalopathy are not thouroughly understood. Various theories may explain bilirubin transport acoss the blood-brain barrier. Free bilirubin, not bound to albumin, can enter the brain. The permeability of the blood brain barrier to bilirubin or albuimin and bilirubin binding may play an important role in the bilirubin encephalopathy. Bilirubin binding ability of Korean infants, similar to American infants, is shown to be less than that of adults. Factors influencing bilirubin-albumin binding, such as acidosis,hypoxia, sepsis, hypothermia, hypoglycemia and immaturity should be considered for neonates at high risk of bilirubin encephalopathy. Free bilirubin is found to be significantly increased in preterm infants with low albumin level. Sulfisoxazole inhibits the bilirubin-albumin binding that resulted in increased free bilirubin concentrations even at low total bilirubin levels. Phenobarbital has no effects on bilirubin binding capacity of albumin. Phototherapy for 48 hours has no influence on bilirubin-albumin binding capacitiy and affinity. Auditory evoked repsonse (ABR) changes in the form of I, III, and IV wave reduction are associated with brainstem and cerebellum bilirubin deposition. Since early detection of bilirubin neurotoxicity is promising for improving outcome for high risk neonates, ABR and other electrophysiological measure will be useful.
Abstract
During the last 30 years, there has been much advances in the understanding of pathogenisis of neonatal hyperbilirubinemia, but the risk of bilirubin encephalopathy are still remained for the high risk neonates. The mechanisms of bilirubin encephalopathy are not thouroughly understood. Various theories may explain bilirubin transport acoss the blood-brain barrier. Free bilirubin, not bound to albumin, can enter the brain. The permeability of the blood brain barrier to bilirubin or albuimin and bilirubin binding may play an important role in the bilirubin encephalopathy. Bilirubin binding ability of Korean infants, similar to American infants, is shown to be less than that of adults. Factors influencing bilirubin-albumin binding, such as acidosis,hypoxia, sepsis, hypothermia, hypoglycemia and immaturity should be considered for neonates at high risk of bilirubin encephalopathy. Free bilirubin is found to be significantly increased in preterm infants with low albumin level. Sulfisoxazole inhibits the bilirubin-albumin binding that resulted in increased free bilirubin concentrations even at low total bilirubin levels. Phenobarbital has no effects on bilirubin binding capacity of albumin. Phototherapy for 48 hours has no influence on bilirubin-albumin binding capacitiy and affinity. Auditory evoked repsonse (ABR) changes in the form of I, III, and IV wave reduction are associated with brainstem and cerebellum bilirubin deposition. Since early detection of bilirubin neurotoxicity is promising for improving outcome for high risk neonates, ABR and other electrophysiological measure will be useful.
참고문헌 (32)
- Lee C, "Neonatal hyperbilirubinemia", J Korean Pediatr Soc, 29, pp.1~5 (1986)
- Lee C, "Recent Advances in neonatal hyperbilirubinemia", J Korean Med Assoc, 37, pp.811~816 (1994)
- Stern L, "Bilirubin metabolism in the newborn; Historical perspective and future directions, In Bilirubin", pp.25~31 (1982), Mead Johnson & Co
- 이상락, "신생아황달", Korean Journal of Pediatrics, 49(1), pp.6~13 (2006), 대한소아과학회
- Truman P, "Jaundice in the preterm infant", Paediatr Nurs, 18, pp.20~22 (2006)
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia, "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation", Pediatrics, 114, pp.297~316 (2004)
- 윤용호, "건강한 만삭아에서 모유황달의 발생 빈도", Korean Journal of Pediatrics, 50(11), pp.1072~1077 (2007), 대한소아과학회
- Maisels MJ, "Normal serum bilirubin levels in the newborn and the effect of breast-feeding", Pediatrics, 78, pp.837~843 (1986)
- Watson RL, "Hyperbilirubinemia", Crit Care Nurs Clin North Am, 21, pp.97~120 (2009)
- Johnson L, "Clinical report from the pilot USA Kernicterus Registry (1992 to 2004)", J Perinatol, 29(Suppl 1), pp.S25~S45 (2009)
- Bhutani VK, "Kernicterus: epidemiological strategies for its prevention through systems-based approaches", J Perinatol, 24, pp.650~662 (2004)
- 최은정, "정상 만삭아에서 신생아실 퇴원 후 재입원에 대한 연구", 대한주산의학회잡지, 20(1), pp.52~59 (2009), 대한주산의학회
- Schwartz HP, "Hyperbilirubinemia: current guidelines and emerging therapies", Pediatr Emerg Care, 27, pp.884~889 (2011)
- Kim JN, "The effect of phenobarbital on bilirubin binding capacity of albmin", pp.1995
- Kim JN, "The effects on the free bilirubin concentration by gestational age and seum albummin level", J Korean Soc Neonatol, pp.258~263 (1995)
- Cashore WJ, "Influence of gestational age and clinical status on bilirubin-binding capacity in newborn infants. Sephadex G-25 gel filtration technique", Am J Dis Child, 131, pp.898~901 (1977)
- Lee JB, "Bilirubin-binding capacity of albumin in Korean neonate", J Korean Pediatr Soc, 31, pp.1259~1266 (1988)
- Cashore WJ, "Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants", J Pediatr, 96, pp.521~527 (1980)
- Alkalay AL, "Hyperbilirubinemia guidelines in newborn infants", Pediatrics, 115, pp.824~825 (2005)
- Ryu IS, "The effect of phototherapy on serum bilirubin binding capacity and affinity in the neonate", J Korean Pediatr Soc, 331, pp.319~325 (1990)
- Lee SL, "Effect of high-dose intravenous immune globulin in the treatment of neonatal immune hemolytic jaundice", Korean J Perinatol, 10, pp.176~182 (1999)
- Odell GB, "Studies in kernicterus. I. The protein binding of bilirubin", J Clin Invest, 38, pp.823~833 (1959)
- Levine RL, "Entry of bilirubin into the brain due to opening of the blood-brain barrier", Pediatrics, 69, pp.255~259 (1982)
- Lee C, "Postnatal maturation of the blood-brain barrier for unbound bilirubin in newborn piglets", Brain Res, 689, pp.233~238 (1995)
- Volpe JJ, "Bilirubin and brain injury, In Neurology of the newborn", pp.619~651 (2008), Saunders
- Lee C, "Permeability of the blood brain barrier for 125I-albumin-bound bilirubin in newborn piglets", Pediatr Res, 25, pp.452~456 (1989)
- Wennberg RP, "Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: improvement with exchange transfusion", J Pediatr, 100, pp.624~626 (1982)
- Gupta AK, "Is auditory brainstem response a bilirubin neurotoxicity marker?", Am J Otolaryngol, 19, pp.232~236 (1998)
- Karplus M, "The effects of brain bilirubin deposition on auditory brain stem evoked responses in rats", Early Hum Dev, 16, pp.185~194 (1988)
- Nakamura H, "Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia", Pediatrics, 75, pp.703~708 (1985)
- Bin JH, "Current trends of the hyperbilirubinemia and the results of auditory evoked potential", Korean J Perinatol, 18, pp.407~414 (2007)
- 장재원, "조기 모유 황달에서 핵황달의 조기 예측도구로서의 청성 뇌간유발 반응 검사의 유용성", Korean Journal of Pediatrics, 50(9), pp.848~854 (2007), 대한소아과학회